Recombinant Human TIFA

Alternative Names:Putative MAPK activating protein PM14 Protein, Putative MAPK-activating protein PM14 Protein, Putative NF kappa B activating protein 20 Protein, Putative NF-kappa-B-activating protein 20 Protein, T2BP Protein, TIFA Protein, TIFA_HUMAN Protein, TRAF interacting protein with FHA domain containing protein A Protein
Catalogue No.:P6383Uniprot ID:Q96CG3
Host:E.ColiExpression Region:1-184
Mol. Weight:20.1 kDaTags:N-terminal His Tag or N-terminal His-IF2DI Tag, determined during production process
  • SPECIFICATIONS
Product Name
Recombinant Human TIFA
Catalogue No.
P6383
Species
Human
Host
E.Coli
Expression Region
1-184
Mol. Weight
20.1 kDa
Tags
N-terminal His Tag or N-terminal His-IF2DI Tag, determined during production process
Purity
Greater than 95% as determined by SDS-PAGE
Application
Western Blot, ELISA
Formulation
Lyophilized from a 0.2 μm filtered solution in 10 mM Hepes, 500 mM NaCl with 5% trehalose, pH7.4
Reconstitution
Centrifuge the vial prior to opening, reconstitute in sterile distilled water or buffer of interest to concentration of 0.1-1mg/ml by gently pipetting 2-3 times, don't vortex
Storage
The lyophilized protein is stable at -20°C for up to 1 year, the protein solution can be stored at 2-8°C for up to 1 week. For extended storage, it is recommended to further dilute in a buffer containing 0.1% BSA (make sure BSA will NOT interfere with your experiment ) and store in working aliquots at -20°C to -80°C for 6 months. Avoid repeated freeze/thaw cycle.
Alternative Names
Putative MAPK activating protein PM14 Protein, Putative MAPK-activating protein PM14 Protein, Putative NF kappa B activating protein 20 Protein, Putative NF-kappa-B-activating protein 20 Protein, T2BP Protein, TIFA Protein, TIFA_HUMAN Protein, TRAF interacting protein with FHA domain containing protein A Protein